5408792025-10-012025-12-315408792025-12-315408792025-04-012025-12-315408792025-10-012025-12-31in-capmkt:OtherExpenses1Member5408792025-10-012025-12-31in-capmkt:OtherExpenses2Member5408792025-10-012025-12-31in-capmkt:OtherExpenses3Member5408792025-10-012025-12-31in-capmkt:OtherExpenses4Member5408792025-10-012025-12-31in-capmkt:OtherExpenses5Member5408792025-10-012025-12-31in-capmkt:OtherExpenses6Member5408792025-10-012025-12-31in-capmkt:OtherExpenses7Member5408792025-10-012025-12-31in-capmkt:OtherExpenses8Member5408792025-10-012025-12-31in-capmkt:OtherExpenses9Member5408792025-10-012025-12-31in-capmkt:OtherExpenses10Member5408792025-04-012025-12-31in-capmkt:OtherExpenses1Member5408792025-04-012025-12-31in-capmkt:OtherExpenses2Member5408792025-04-012025-12-31in-capmkt:OtherExpenses3Member5408792025-04-012025-12-31in-capmkt:OtherExpenses4Member5408792025-04-012025-12-31in-capmkt:OtherExpenses5Member5408792025-04-012025-12-31in-capmkt:OtherExpenses6Member5408792025-04-012025-12-31in-capmkt:OtherExpenses7Member5408792025-04-012025-12-31in-capmkt:OtherExpenses8Member5408792025-04-012025-12-31in-capmkt:OtherExpenses9Member5408792025-04-012025-12-31in-capmkt:OtherExpenses10Member5408792025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15408792025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25408792025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15408792025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25408792025-12-31Statement15408792025-10-012025-12-31Statement15408792025-12-31Statement25408792025-10-012025-12-31Statement25408792025-12-31Statement35408792025-10-012025-12-31Statement35408792025-12-31Statement45408792025-10-012025-12-31Statement45408792025-12-31Statement55408792025-10-012025-12-31Statement55408792025-12-31StatementDynamic1I1Statement15408792025-12-31StatementDynamic1I2Statement15408792025-12-31StatementDynamic1I3Statement15408792025-12-31StatementDynamic1I4Statement15408792025-12-31StatementDynamic2I1Statement25408792025-12-31StatementDynamic2I2Statement25408792025-12-31StatementDynamic2I3Statement25408792025-12-31StatementDynamic2I4Statement25408792025-12-31StatementDynamic3I1Statement35408792025-12-31StatementDynamic3I2Statement35408792025-12-31StatementDynamic3I3Statement35408792025-12-31StatementDynamic3I4Statement35408792025-12-31StatementDynamic4I1Statement45408792025-12-31StatementDynamic4I2Statement45408792025-12-31StatementDynamic4I3Statement45408792025-12-31StatementDynamic4I4Statement45408792025-12-31StatementDynamic5I1Statement55408792025-12-31StatementDynamic5I2Statement55408792025-12-31StatementDynamic5I3Statement55408792025-12-31StatementDynamic5I4Statement5iso4217:INRxbrli:pureiso4217:INRxbrli:shares540879APOLLONOTLISTEDINE713T01028APOLLO MICRO SYSTEMS LIMITEDMain BoardEquity2025-04-012026-03-312026-02-092026-02-02INRLakhsQuarterlyThird quarterSingle segmentElectromechanical components and systems and allied components and services2026-02-0911:30:002026-02-0915:20:00Not applicabletrue5falseNot Applicable2025-10-012025-12-31UnauditedStandalone2007839000441850002052024000154281700001935650006847500087077000513450005729300020005720005145200005145200058752000732270001319790000-805270000000-805270001504000-7902300035729200010.930.91000.930.912025-04-012025-12-31UnauditedStandalone559631400089312000568562600043416920000-616232000188768000288544000143635000147213000449362000011920060000119200600022244100013825000036069100008313150000000831315000150400083281900035729200012.512.47002.512.47Business development expenses1681000Consultancy charges12763000Travelling expenses7044000Power and fuel2313000Rent435000Insurance3612000Filing Fee10000Conveyance1572000Office maintenance2459000Other Expenses25404000Business development expenses4716000Consultancy charges34289000Travelling expenses20394000Power and fuel6725000Rent1305000Insurance10726000Filing Fee55000Conveyance4878000Office maintenance5538000Other Expenses58587000Re-measurement gains/ (losses) on defined benefit plan2122000Income tax effect-6180001504000Re-measurement gains/ (losses) on defined benefit plan2122000Income tax effect-6180001504000000015040001504000Preferential Issues2025-11-123000024000002025-12-31trueAcuite Ratings and Research LimitedfalseNot ApplicableNot ApplicableNot ApplicableKarunakar Reddy BaddamManaging DirectorHyderabad2026-02-09Preferential Issues2025-11-195616495000000002025-12-31trueAcuite Ratings and Research LimitedfalseNot ApplicableNot ApplicableNot ApplicablePreferential Issues2025-11-261038650922000002025-12-31trueAcuite Ratings and Research LimitedfalseNot ApplicableNot ApplicableNot ApplicablePreferential Issues2025-12-02247013262000002025-12-31trueAcuite Ratings and Research LimitedfalseNot ApplicableNot ApplicableNot ApplicablePreferential Issues2025-12-221000008000002025-12-31trueAcuite Ratings and Research LimitedfalseNot ApplicableNot ApplicableNot ApplicableWorking Capital RequirementNot Applicable5000000000454770000000The Company has allotted 35088 equity shares of Rs. 1/- each upon exercise of warrants issued on Preferential issue basis and the same are yet to be listed on stock exchanges as the listing approval is pending as on 31st December, 2025. The amount raised against the said allotment is yet to be utilized <br></br> <br></br> an amount of Rs.18,01,65,087, which was received during the quarter ended 30th September, 2025 being 75% of the warrant application monies towards 21,07,194 share warrants, has been utilized during the quarter ended 31st December 2025. The utilization of these funds has been in accordance with the objects and there has been no deviation for which the funds have been raised.Research & Development Expenditure for development of futuristic technologiesNot Applicable75000000068210000000Investment in Subsidiar(y)iesNot Applicable66000000060030000000General Corporate PurposesNot Applicable1750800000159240000000Working Capital RequirementNot Applicable5000000000454770000000The Company has allotted 6569000 equity shares of Rs. 1/- each upon exercise of warrants issued on Preferential issue basis and the same are yet to be listed on stock exchanges as the listing approval is pending as on 31st December, 2025. The amount raised against the said allotment is yet to be utilized. <br></br> <br></br> An amount of Rs.18,01,65,087, which was received during the quarter ended 30th September, 2025 being 75% of the warrant application monies towards 21,07,194 share warrants, has been utilized during the quarter ended 31st December 2025. The utilization of these funds has been in accordance with the objects and there has been no deviation for which the funds have been raised.Research & Development Expenditure for development of futuristic technologiesNot Applicable75000000068210000000Investment in Subsidiar(y)iesNot Applicable66000000060030000000General Corporate PurposesNot Applicable1750800000159240000000Working Capital RequirementNot Applicable5000000000454770000000The Company has allotted 12147964 equity shares of Rs. 1/- each upon exercise of warrants issued on Preferential issue basis and the same are yet to be listed on stock exchanges as the listing approval is pending as on 31st December, 2025. The amount raised against the said allotment is yet to be utilized <br></br> <br></br> an amount of Rs.18,01,65,087, which was received during the quarter ended 30th September, 2025 being 75% of the warrant application monies towards 21,07,194 share warrants, has been utilized during the quarter ended 31st December 2025. The utilization of these funds has been in accordance with the objects and there has been no deviation for which the funds have been raised.Research & Development Expenditure for development of futuristic technologiesNot Applicable75000000068210000000Investment in Subsidiar(y)iesNot Applicable66000000060030000000General Corporate PurposesNot Applicable1750800000159240000000Working Capital RequirementNot Applicable5000000000454770000000The Company has allotted 2889044 equity shares of Rs. 1/- each upon exercise of warrants issued on Preferential issue basis and the same are yet to be listed on stock exchanges as the listing approval is pending as on 31st December, 2025. The amount raised against the said allotment is yet to be utilized <br></br> <br></br> an amount of Rs.18,01,65,087, which was received during the quarter ended 30th September, 2025 being 75% of the warrant application monies towards 21,07,194 share warrants, has been utilized during the quarter ended 31st December 2025. The utilization of these funds has been in accordance with the objects and there has been no deviation for which the funds have been raised.Research & Development Expenditure for development of futuristic technologiesNot Applicable75000000068210000000Investment in Subsidiar(y)iesNot Applicable66000000060030000000General Corporate PurposesNot Applicable1750800000159240000000Working Capital RequirementNot Applicable5000000000454770000000The Company has allotted 11696 equity shares of Rs. 1/- each upon exercise of warrants issued on Preferential issue basis and the same are yet to be listed on stock exchanges as the listing approval is pending as on 31st December, 2025. The amount raised against the said allotment is yet to be utilized <br></br> <br></br> an amount of Rs.18,01,65,087, which was received during the quarter ended 30th September, 2025 being 75% of the warrant application monies towards 21,07,194 share warrants, has been utilized during the quarter ended 31st December 2025. The utilization of these funds has been in accordance with the objects and there has been no deviation for which the funds have been raised.Research & Development Expenditure for development of futuristic technologiesNot Applicable75000000068210000000Investment in Subsidiar(y)iesNot Applicable66000000060030000000General Corporate PurposesNot Applicable1750800000159240000000